- Home
- ZI vs RNA Comparison
ZI vs RNA Comparison
Compare ZI & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZI
- RNA
- Stock Information
- Founded
- ZI 2007
- RNA 2012
- Country
- ZI United States
- RNA United States
- Employees
- ZI N/A
- RNA N/A
- Industry
- ZI Computer Software: Prepackaged Software
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- ZI Technology
- RNA Health Care
- Exchange
- ZI Nasdaq
- RNA Nasdaq
- Market Cap
- ZI 3.5B
- RNA 3.7B
- IPO Year
- ZI 2020
- RNA 2020
- Fundamental
- Price
- ZI $9.65
- RNA $31.12
- Analyst Decision
- ZI Hold
- RNA Strong Buy
- Analyst Count
- ZI 20
- RNA 10
- Target Price
- ZI $12.05
- RNA $65.80
- AVG Volume (30 Days)
- ZI 4.9M
- RNA 1.3M
- Earning Date
- ZI 02-25-2025
- RNA 03-07-2025
- Dividend Yield
- ZI N/A
- RNA N/A
- EPS Growth
- ZI N/A
- RNA N/A
- EPS
- ZI 0.02
- RNA N/A
- Revenue
- ZI $1,221,600,000.00
- RNA $10,117,000.00
- Revenue This Year
- ZI N/A
- RNA N/A
- Revenue Next Year
- ZI N/A
- RNA N/A
- P/E Ratio
- ZI $399.90
- RNA N/A
- Revenue Growth
- ZI N/A
- RNA N/A
- 52 Week Low
- ZI $7.65
- RNA $13.73
- 52 Week High
- ZI $17.70
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- ZI 39.14
- RNA 44.06
- Support Level
- ZI $9.98
- RNA $31.14
- Resistance Level
- ZI $10.64
- RNA $33.37
- Average True Range (ATR)
- ZI 0.34
- RNA 1.67
- MACD
- ZI -0.04
- RNA -0.16
- Stochastic Oscillator
- ZI 1.98
- RNA 11.27
About ZI ZoomInfo Technologies Inc
ZoomInfo Technologies Inc provides a go-to-market intelligence platform for sales and marketing teams. Its cloud-based go-to-market data and insights platform deliver comprehensive and high-quality intelligence and analytics to provide sales and marketing professionals with accurate information and insights on the organizations and professionals. Nearly all of its revenue is derived from the United States.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.